Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat

Stroke. 1998 Aug;29(8):1650-5. doi: 10.1161/01.str.29.8.1650.

Abstract

Background and purpose: Neuronal injury results from an insufficient supply of oxygen to the brain. This experiment examined whether a pharmacologically induced rightward shift of the partial pressure of oxygen at which 50% of hemoglobin is saturated (P50) would improve outcome from either incomplete and/or near-complete forebrain ischemia-induced hypoxia in the rat.

Methods: For incomplete ischemia (attenuated electroencephalogram), fasted rats (n = 17 to 19 per group) were given a synthetic allosteric modifier of hemoglobin affinity for oxygen (RSR13; 150 mg/kg IV) before or immediately after 20 minutes of bilateral carotid occlusion combined with a decrease in mean arterial pressure to 40 mm Hg. For near-complete ischemia (isoelectric electroencephalogram), rats (n = 15 per group) were given RSR13 (150 mg/kg) at onset of reperfusion after 10 minutes of bilateral carotid occlusion combined with a decrease in mean arterial pressure to 30 mm Hg. In both experiments, control rats were given vehicle (0.9% NaCl IV) only. Outcome (defined as percent dead hippocampal CA1 neurons) was determined at 5 days after ischemia.

Results: RSR13 (150 mg/kg) produced a 68% rightward shift of P50 (34+/-3 to 57+/-8 mm Hg). RSR13 reduced CA1 damage resulting from incomplete ischemia by 28% (P=0.02), but only when administered at the onset of reperfusion. RSR13 had no effect on outcome from near-complete ischemia.

Conclusions: A postischemic pharmacologically induced increase in P50 may improve outcome from incomplete global cerebral ischemia. More severe (near-complete) ischemia negates this benefit.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Allosteric Regulation
  • Aniline Compounds / pharmacology*
  • Animals
  • Antisickling Agents / pharmacology*
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Cerebrovascular Circulation / drug effects
  • Cross-Linking Reagents / pharmacology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Male
  • Oxygen / blood*
  • Oxyhemoglobins / chemistry
  • Oxyhemoglobins / metabolism*
  • Propionates / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / metabolism
  • Treatment Outcome

Substances

  • Aniline Compounds
  • Antisickling Agents
  • Cross-Linking Reagents
  • Oxyhemoglobins
  • Propionates
  • efaproxiral
  • Oxygen